Differences in bioactivity between human insulin and insulin analogues approved for therapeutic use- compilation of reports from the past 20 years

In order to provide comprehensive information on the differences in bioactivity between human insulin and insulin analogues, published in vitro comparisons of human insulin and the rapid acting analogues insulin lispro (Humalog(®)), insulin aspart ( NovoRapid(®)), insulin glulisine (Apidra(®)), and...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Haim, Chantelau, Ernst A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160352/
https://www.ncbi.nlm.nih.gov/pubmed/21714872
http://dx.doi.org/10.1186/1758-5996-3-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160352/
https://www.ncbi.nlm.nih.gov/pubmed/21714872
http://dx.doi.org/10.1186/1758-5996-3-13

Ejemplares similares